Related Experiment Videos
Thymic lymphomas in mice with a truncating mutation in Brca2
L S Friedman1, F C Thistlethwaite, K J Patel
1Cancer Research Campaign, Human Cancer Genetics Research Group, Cambridge University, Addenbrooke's Hospital, United Kingdom.
Cancer Research
|April 16, 1998
Summary
This study created a Brca2 gene mutation in mice, leading to early death in most homozygous mutants. Surviving adults developed thymic lymphomas, highlighting Brca2
Area of Science:
- Genetics
- Cancer Biology
- Mouse Models
Background:
- Mutations in the BRCA2 gene are linked to hereditary breast and ovarian cancers in women.
- Understanding Brca2 function in vivo is crucial for cancer research.
Purpose of the Study:
- To investigate the in vivo function of the Brca2 gene.
- To establish a mouse model for Brca2-associated cancers.
Main Methods:
- Generated a targeted mutation in the mouse Brca2 gene (Brca2(tm1Cam)) by introducing a premature stop codon in exon 11.
- Phenotypic analysis of homozygous and heterozygous Brca2 mutant mice.
Main Results:
- Brca2(tm1Cam) homozygous mutant mice exhibit high lethality, with 90% dying prenatally or perinatally.
- Adult homozygous mutants that survived developed thymic lymphomas between 12-14 weeks of age.
- Heterozygous mice showed no tumor development up to 10 months.
Conclusions:
- The Brca2(tm1Cam) mutation causes early lethality and thymic lymphomas in mice, mirroring human BRC A2-associated cancer phenotypes.
- This mouse model is valuable for studying Brca2 function and developing cancer therapies.